---
title: lis
description: Understand the usage of 'lis' function that prints latest insider sales
  for stocks. You can limit the amount of datarows to be displayed. This comes from
  OpenInsider source and can help understand Insider trading data.
keywords:
- Print latest insider sales
- OpenInsider
- Stocks
- Insider data
- Trading
- Stock markets
- Financial data
- Script
---

import HeadTitle from '@site/src/components/General/HeadTitle.tsx';

<HeadTitle title="stocks/ins/lis - Reference | OpenBB Terminal Docs" />

Print latest insider sales. [Source: OpenInsider]

### Usage

```python
lis [-l LIMIT]
```

---

## Parameters

| Name | Description | Default | Optional | Choices |
| ---- | ----------- | ------- | -------- | ------- |
| limit | Limit of datarows to display | 10 | True | None |


---

## Examples

```python
2022 Feb 16, 07:56 (ğŸ¦‹) /stocks/ins/ $ lis
                                                                               Insider Data
â”â”â”â”â”³â”â”â”â”â”â”â”â”â”â”â”â”â”â”³â”â”â”â”â”â”â”â”â”â”â”â”â”³â”â”â”â”â”â”â”â”â”³â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”³â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”³â”â”â”â”â”â”â”â”â”â”â”â”â”³â”â”â”â”â”â”â”â”â”â”â”â”â”â”³â”â”â”â”â”â”â”â”â”â”³â”â”â”â”â”â”â”â”â”â”³â”â”â”â”â”â”â”â”â”â”â”â”³â”â”â”â”â”â”â”â”â”â”â”³â”â”â”â”â”â”â”â”â”â”â”â”â”â”“
â”ƒ X â”ƒ Filing Date â”ƒ Trade Date â”ƒ Ticker â”ƒ Company Name         â”ƒ Insider Name        â”ƒ Title      â”ƒ Trade Type  â”ƒ Price   â”ƒ Qty     â”ƒ Owned     â”ƒ Diff Own â”ƒ Value       â”ƒ
â”¡â”â”â”â•‡â”â”â”â”â”â”â”â”â”â”â”â”â”â•‡â”â”â”â”â”â”â”â”â”â”â”â”â•‡â”â”â”â”â”â”â”â”â•‡â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â•‡â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â•‡â”â”â”â”â”â”â”â”â”â”â”â”â•‡â”â”â”â”â”â”â”â”â”â”â”â”â”â•‡â”â”â”â”â”â”â”â”â”â•‡â”â”â”â”â”â”â”â”â”â•‡â”â”â”â”â”â”â”â”â”â”â”â•‡â”â”â”â”â”â”â”â”â”â”â•‡â”â”â”â”â”â”â”â”â”â”â”â”â”â”©
â”‚ D â”‚ 2022-02-15  â”‚ 2022-02-14 â”‚ BVS    â”‚ Bioventus Inc.       â”‚ D'Adamio Anthony    â”‚ SVP, GC    â”‚ S - Sale+OE â”‚ $11.99  â”‚ -1,294  â”‚ 18,672    â”‚ -6%      â”‚ -$15,513    â”‚
â”‚   â”‚ 21:31:03    â”‚            â”‚        â”‚                      â”‚                     â”‚            â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”œâ”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ D â”‚ 2022-02-15  â”‚ 2022-02-14 â”‚ BVS    â”‚ Bioventus Inc.       â”‚ Anglum Gregory O.   â”‚ SVP, CFO   â”‚ S - Sale+OE â”‚ $11.99  â”‚ -1,294  â”‚ 55,013    â”‚ -2%      â”‚ -$15,518    â”‚
â”‚   â”‚ 21:27:43    â”‚            â”‚        â”‚                      â”‚                     â”‚            â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”œâ”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ D â”‚ 2022-02-15  â”‚ 2022-02-14 â”‚ BVS    â”‚ Bioventus Inc.       â”‚ Nosenzo John        â”‚ Chief      â”‚ S - Sale+OE â”‚ $11.99  â”‚ -534    â”‚ 43,370    â”‚ -1%      â”‚ -$6,401     â”‚
â”‚   â”‚ 21:17:44    â”‚            â”‚        â”‚                      â”‚                     â”‚ Commercial â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”‚   â”‚             â”‚            â”‚        â”‚                      â”‚                     â”‚ Officer    â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”œâ”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ D â”‚ 2022-02-15  â”‚ 2022-02-11 â”‚ PGNY   â”‚ Progyny, Inc.        â”‚ Schlanger David J   â”‚ Exec COB   â”‚ S - Sale+OE â”‚ $42.00  â”‚ -1,000  â”‚ 84,000    â”‚ -1%      â”‚ -$42,000    â”‚
â”‚   â”‚ 21:09:05    â”‚            â”‚        â”‚                      â”‚                     â”‚            â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”œâ”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ D â”‚ 2022-02-15  â”‚ 2022-02-15 â”‚ EW     â”‚ Edwards Lifesciences â”‚ Mussallem Michael A â”‚ COB, CEO   â”‚ S - Sale+OE â”‚ $110.09 â”‚ -32,550 â”‚ 3,820,007 â”‚ -1%      â”‚ -$3,583,289 â”‚
â”‚   â”‚ 20:50:39    â”‚            â”‚        â”‚ Corp                 â”‚                     â”‚            â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”œâ”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ D â”‚ 2022-02-15  â”‚ 2022-02-11 â”‚ AGCO   â”‚ Agco Corp /de        â”‚ Beck Andrew H       â”‚ SVP, CFO   â”‚ S - Sale+OE â”‚ $131.83 â”‚ -25,000 â”‚ 107,337   â”‚ -19%     â”‚ -$3,295,750 â”‚
â”‚   â”‚ 20:38:48    â”‚            â”‚        â”‚                      â”‚                     â”‚            â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”œâ”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ D â”‚ 2022-02-15  â”‚ 2022-02-14 â”‚ PUBM   â”‚ Pubmatic, Inc.       â”‚ Goel Amar K.        â”‚ Chief      â”‚ S - Sale+OE â”‚ $29.85  â”‚ -24,000 â”‚ 0         â”‚ -100%    â”‚ -$716,444   â”‚
â”‚   â”‚ 20:24:51    â”‚            â”‚        â”‚                      â”‚                     â”‚ Innovation â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”‚   â”‚             â”‚            â”‚        â”‚                      â”‚                     â”‚ Officer,   â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”‚   â”‚             â”‚            â”‚        â”‚                      â”‚                     â”‚ 10%        â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”œâ”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ D â”‚ 2022-02-15  â”‚ 2022-02-14 â”‚ NET    â”‚ Cloudflare, Inc.     â”‚ Meresman Stanley J  â”‚ Dir        â”‚ S - Sale+OE â”‚ $106.00 â”‚ -18,622 â”‚ 2,441     â”‚ -88%     â”‚ -$1,973,993 â”‚
â”‚   â”‚ 19:57:51    â”‚            â”‚        â”‚                      â”‚                     â”‚            â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”œâ”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ D â”‚ 2022-02-15  â”‚ 2022-02-14 â”‚ AON    â”‚ Aon Plc              â”‚ Davies Christa      â”‚ CFO        â”‚ S - Sale+OE â”‚ $283.72 â”‚ -616    â”‚ 200,237   â”‚ 0%       â”‚ -$174,772   â”‚
â”‚   â”‚ 19:36:49    â”‚            â”‚        â”‚                      â”‚                     â”‚            â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”œâ”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ D â”‚ 2022-02-15  â”‚ 2022-02-15 â”‚ RYTM   â”‚ Rhythm               â”‚ Shulman Joseph      â”‚ Chief      â”‚ S - Sale+OE â”‚ $6.10   â”‚ -557    â”‚ 1,006     â”‚ -36%     â”‚ -$3,398     â”‚
â”‚   â”‚ 19:32:08    â”‚            â”‚        â”‚ Pharmaceuticals,     â”‚                     â”‚ Technical  â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â”‚   â”‚             â”‚            â”‚        â”‚ Inc.                 â”‚                     â”‚ Officer    â”‚             â”‚         â”‚         â”‚           â”‚          â”‚             â”‚
â””â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
D: Derivative transaction in filing (usually option exercise)
```
---
